Under the terms of the Convention, the States Parties undertake not to develop, produce, stockpile, or acquire biological agents or toxins “of types and in quantities that have no justification for prophylactic, protective, and other peaceful purposes,” as well as weapons and means of delivery designed to use such agents or toxins for hostile purposes or in armed conflict.
Opened for signature in 1972 and entered into force in 1975, the BWC is the premier international forum that addresses biological threats, and is evolving to meet changing world needs. Accordingly, the BWC charges members of the security, health, scientific, law enforcement and business fields to better address biological threats, whether intentional, accidental or natural.
Bioweapons continue to remain a risk because new discoveries and technologies are evolving in unpredictable ways and will continue to become globally available.
- The BWC effectively prohibits the development, production, acquisition, transfer, retention, stockpiling and use of biological and toxin weapons;
- It was the first multilateral disarmament treaty banning an entire category of weapons; is a key element in the international community’s efforts to address the proliferation of weapons of mass destruction;
- As of April 2013, the BWC has 170 States Parties and 12 Signatory States; the USG continues to actively encourage universal membership;
- Opened for signature in 1972 and entered into force in 1975:
- Review Conferences are held every 5 years in Geneva in addition to annual inter-sessional meetings of States Parties and experts;
- Review Conferences focus on specific issues designed to keep the treaty in a position to address ever-changing nature of biological threats.
- Supported by the a three-member staff based in Geneva.
- The ability to exploit such advances will become increasingly accessible to those with ill intent as the barriers of technical expertise and monetary costs decline;
- We cannot be complacent but instead must take action to ensure that advances in the life sciences positively affect people of all nations, while we reduce the risks posed by their misuse.